359 related articles for article (PubMed ID: 25103652)
1. Experience with Boston keratoprosthesis type 1 in the developing world.
de Oliveira LA; Pedreira Magalhães F; Hirai FE; de Sousa LB
Can J Ophthalmol; 2014 Aug; 49(4):351-7. PubMed ID: 25103652
[TBL] [Abstract][Full Text] [Related]
2. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
3. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
4. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
Zerbe BL; Belin MW; Ciolino JB;
Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
[TBL] [Abstract][Full Text] [Related]
5. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
6. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
[TBL] [Abstract][Full Text] [Related]
7. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
8. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
9. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
10. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
11. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
12. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
[TBL] [Abstract][Full Text] [Related]
13. Boston type 1 keratoprosthesis for primary congenital glaucoma.
Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort.
Srikumaran D; Munoz B; Aldave AJ; Aquavella JV; Hannush SB; Schultze R; Belin M; Akpek EK
Ophthalmology; 2014 Nov; 121(11):2159-64. PubMed ID: 25017414
[TBL] [Abstract][Full Text] [Related]
15. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
Verdejo-Gómez L; Peláez N; Gris O; Güell JL
Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
[TBL] [Abstract][Full Text] [Related]
16. International results with the Boston type I keratoprosthesis.
Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
[TBL] [Abstract][Full Text] [Related]
17. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
20. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]